Literature DB >> 21044727

Gastrocolic fistula as a cause of persistent diarrhea in a patient with a gastrostomy tube.

Young Jin Joo1, Jung Hoi Koo, Sun Hong Song.   

Abstract

A 60-year-old man with a history of recurrent strokes secondary to moyamoya disease underwent insertion of a percutaneous radiologic gastrostomy tube because of severe dysphagia. Feeding was continued for 5 months after the procedure without complications. Persistent diarrhea began 2 weeks after admission for comprehensive rehabilitation. Conservative treatment was not effective. Sigmoidoscopy showed a U-shaped tube suggestive of a gastrocolic fistula in the transverse colon. This was confirmed by means of a tubogram obtained through a gastrostomy tube. The diarrhea resolved after changing the gastrostomy tube. This case report highlights the importance of considering other uncommon conditions, such as a gastrocolic fistula, in the differential diagnosis of persistent diarrhea in a patient with a gastrostomy tube.
Copyright © 2010 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21044727     DOI: 10.1016/j.apmr.2010.07.224

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  3 in total

1.  Inadvertent Percutaneous Endoscopic Gastrostomy Tube Placement through the Transverse Colon to the Stomach Causing Intractable Diarrhea: A Case Report.

Authors:  David T Burke; Andrew I Geller; Alexios G Carayannopoulos; Richard Goldstein
Journal:  Diagn Ther Endosc       Date:  2011-12-20

2.  Two cases of gastrocolocutaneous fistula with a long asymptomatic period after percutaneous endoscopic gastrostomy.

Authors:  Hyo Sun Kim; Chang Seok Bang; Yeon Soo Kim; Oh Kyung Kwon; Min Sun Park; Jeong Ho Eom; Gwang Ho Baik; Dong Joon Kim
Journal:  Intest Res       Date:  2014-07-25

3.  Gastrocolocutaneous Fistula due to Percutaneous Endoscopic Gastrostomy Placement.

Authors:  Akira Kuriyama
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.